Building on our network result that key gene set 2 is enriched for mitochondrial energy metabolism, the late-stage regulators we identified—UQCR11, NDUFB4, PRDX3, and S100A10—map to pathways that could support or amplify ADSCs-to-tumor bioenergetic coupling. This evidence concerns the gene S100A10 and neoplasm.